FDA raises concerns about experimental sleep aid suvorexant

FDA raises concerns about experimental sleep aid suvorexant

WASHINGTON While an experimental insomnia drug from Merck was effective at helping patients sleep, it also had dangerous side effects including daytime drowsiness and suicidal thinking, a Food and Drug Administration (FDA) advisory committee warned.

5
Like
Save

Comments

Write a comment

*